HIV/AIDS Policy: HIV/AIDS Drug Patents
 J&J Will Not Join Medicines Patent Pool; Company's Pharma Head Says Mechanism Could "Cause Disaster" (January 3, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Tell Johnson & Johnson to Stop Turning Its Back on AIDS Patients (December 15, 2011)
J&J is undermining access to key AIDS drugs.
From Doctors Without Borders
- India's Aurobindo Pharma First Major Generic Drugmaker to Join UNITAID's Medicines Patent Pool (October 11, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Pharmaceutical Companies Should "Get on Board" With Unitaid's "Patent Pools" (October 5, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Europe! Hands Off Our Medicine! (Fall 2010)
A global campaign to stop the attack on affordable medicines.
To read PDF, click here.
In Achieve, from ACRIA and GMHC
- Patents and the Pipeline: Is Access Under Threat? (September 2011)
In 2011 Pipeline Report, from Treatment Action Group and HIV i-Base
- Medicines Patent Pool Licenses First HIV and HBV Drugs (July 18, 2011)
From HIVandHepatitis.com
 More on Generic Antiretrovirals ... A Blog Entry by Paul E. Sax, M.D. (June 13, 2011)
Paul Sax, M.D., learns the true reasons behind why we have yet to see a generic version of Epivir in the U.S.
From Journal Watch
- MSF Letter Criticizes Johnson & Johnson for Not Joining Medicines Patent Pool (April 26, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Patent Information Database for HIV Drugs (April 8, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- UNAIDS, UNDP, WHO Release Policy Brief Advising Countries on Using TRIPS Flexibilities to Drive Down HIV Treatment Costs (March 16, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Supreme Court to Decide on Ownership of University Patents (March 1, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Financial Times Examines Pharma's Growing Interest in India (January 27, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Health Groups Hail India's AIDS Drug Patent Move (January 13, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- U.S. Supreme Court to Decide Stanford University Patent Case (November 5, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- National Institutes of Health Donates Protease Inhibitor Patent to UNITAID Medicines Patent Pool (Autumn 2010)
To read PDF, click here.
In TAGline, from Treatment Action Group
- NIH Announces It Will Share IP Rights to Some AIDS Drugs in UNITAID Patent Pool (October 1, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- News Outlets Report on Medical Intellectual Property Developments, Drug Access Issues (July 22, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- UN Urged to Probe U.S. Trade Stance on Generic Drugs (July 21, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Update 1 -- Some Drug Firms Keen, Others Reluctant on AIDS Pool (July 21, 2010)
From Reuters
- More Details Emerge About UNITAID's Plan for Patent Pool for HIV/AIDS Drugs (December 16, 2009)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- UNITAID to Launch Patent Pool for HIV/AIDS Drugs by Mid-2010 (December 15, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- UNITAID Executive Board Approves Breakthrough Plan to Make AIDS Treatment More Widely Available at Lower Cost (December 14, 2009)
Patent pool could save over one billion dollars a year.
From UNITAID
- Forbes Examines Ongoing Discussions Over HIV/AIDS Drugs Patent Pools (December 11, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Blog: The Prospect of an HIV Patent Pool (November 13, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Pharmaceutical Companies Accept Ecuador's Decision to Break Drug Patents (October 29, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- MSF Calls on Drug Companies to Pool HIV Patents (October 5, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Drug Companies Called on to Pool HIV Patents (September 30, 2009)
From Médecins Sans Frontières
- Canada: Hope for Cheap HIV Drugs Dims (September 21, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- GlaxoSmithKline Spokesman Defends Company's Position on Patent Pools for HIV in Guardian Letter to the Editor (September 10, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Organizations Call on GSK to Join UNITAID Patent Pool (September 9, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Indian Health Officials Welcome Patent Rejections of HIV/AIDS Drugs (September 9, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Drug Patents Come Under Fire at AIDS Conference (August 16, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Agency for Health Care Policy and Research
- Lancet Commends U.K. All-Parliamentary Group on AIDS Call For HIV Drug Patent Pool (July 24, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Glaxo Proposes Patent Pool for Neglected Diseases (February 17, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Brazil May Reject Gilead's AIDS Drug Patent (April 11, 2008)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Thai-Ing to Change the System (February 22, 2008)
U.S. advocates join call for Thailand to stand up to PhRMA and continue life-saving generic drug program.
In Housing Works AIDS Issues Update, from Housing Works
- Gilead Sciences May Lose Patent for Viread (January 25, 2008)
Looser patent laws could mean generic version of Tenofovir to come.
In Housing Works AIDS Issues Update, from Housing Works
- India's Decision to Adhere to International Patent Regulations Could Limit Access to Medicines, Including HIV/AIDS Drugs (January 8, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Developing Countries Should Use Trade Rules to Circumvent Patent Laws on AIDS Drugs, WHO Official Says (September 23, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Medical Innovation and Patent Gridlock (June 20, 2005)
[Archived Article]
John James with a different take on why patents tend to stifle innovation in drug development.
In AIDS Treatment News, from AIDS Treatment News
- Congress Should Vote Down CAFTA Because of Patent Protections on Drugs, Including Antiretrovirals, Opinion Piece Says (May 27, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Patent Primer (February 2002)
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Making Patents Public: Redefining Intellectual Property When AIDS Drugs Are at Issue (October 11, 2001)
From FindLaw.com
- Africa Access: Moving Fast, Outcome Uncertain (February 23, 2001)
In AIDS Treatment News, from AIDS Treatment News
- GATT and the Gap: How to Save Lives (November 20, 1998)
How the Global Agreement on Tariffs and Trade could affect treatment access in developing countries.
From AIDS Treatment News
|
Advertisement
|
Email
Glossary
